← Back
Data updated: Mar 10, 2026
BRILLIAN PHARMA
Cardiovascular
BRILLIAN PHARMA is a pharmaceutical company focused on Cardiovascular. Key products include SDAMLO.
2025
Since
1
Drugs
-
Trials
1
Approved (2yr)
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2025-07-24
- Latest
- 2025-07-24
- Applications
- 1